Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Update

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a large growth in short interest during the month of April. As of April 30th, there was short interest totaling 17,577 shares, a growth of 100.9% from the April 15th total of 8,749 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average trading volume of 220,825 shares, the days-to-cover ratio is presently 0.1 days.

Analyst Upgrades and Downgrades

SGIOY has been the topic of a number of research analyst reports. The Goldman Sachs Group upgraded Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a research note on Wednesday, April 8th. Zacks Research lowered Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong sell” rating in a research note on Thursday, April 16th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce”.

Shionogi & Co., Ltd. Unsponsored ADR Price Performance

Shares of Shionogi & Co., Ltd. Unsponsored ADR stock traded up $0.03 during trading on Friday, hitting $9.70. 129,320 shares of the stock traded hands, compared to its average volume of 177,301. The firm’s fifty day moving average is $10.42 and its 200-day moving average is $9.79. Shionogi & Co., Ltd. Unsponsored ADR has a 52 week low of $7.56 and a 52 week high of $12.00. The stock has a market cap of $16.51 billion, a price-to-earnings ratio of 12.13, a PEG ratio of 0.71 and a beta of 0.10. The company has a quick ratio of 5.21, a current ratio of 5.84 and a debt-to-equity ratio of 0.01.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its quarterly earnings results on Tuesday, May 12th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.15 by $0.03. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 14.09% and a net margin of 41.08%.The firm had revenue of $881.71 million during the quarter, compared to analysts’ expectations of $895.52 million. Research analysts expect that Shionogi & Co., Ltd. Unsponsored ADR will post 0.78 EPS for the current fiscal year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.